Persistent increase in cardiac troponin I in Fabry disease: A case report

BMC Cardiovascular Disorders

Volumn 11, Issue , 2011, Pages

  Tanislav, Christian ^a   Feustel, Andreas ^a   Franzen, Wolfgang ^a   Wüsten, Oliver ^a   Schneider, Christian ^a   Reichenberger, Frank ^a   Rolfs, Arndt ^b   Sieweke, Nicole ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; GADOLINIUM; TROPONIN I; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; DYSPNEA; ELECTROCARDIOGRAM; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; GENETIC ANALYSIS; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HUMAN; NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; Q WAVE; SINUS RHYTHM; ST SEGMENT DEPRESSION; T WAVE; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; MIDDLE AGED;

BIOLOGICAL MARKERS; FABRY DISEASE; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; TROPONIN I;

EID: 79251561559     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-11-6     Document Type: Article

References (20)

1. Mehta A, Ricci R, Widmer U, Dehout F, Garcia de Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 2004, 34:236-242. 10.1111/j.1365-2362.2004.01309.x, 15025684.
2. Weidemann F, Strotmann JM, Breunig F, Niemann M, Maag R, Baron R, Eggert AO, Wanner C. Misleading terms in Anderson-Fabry disease. Eur J Clin Invest 2008, 38:191-196. 10.1111/j.1365-2362.2008.01921.x, 18257782.
3. Hoffmann B. Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring. Orphanet J Rare Dis 2009, 4:21. 10.1186/1750-1172-4-21, 2768700, 19818152.
4. Chimenti C, Morgante E, Tanzilli G, Mangieri E, Critelli G, Gaudio C, Russo MA, Frustaci A. Angina in fabry disease reflects coronary small vessel disease. Circ Heart Fail 2008, 1:161-169. 10.1161/CIRCHEARTFAILURE.108.769729, 19808286.
5. Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, Yoshida H, Horinouchi M, Tabata K, Yonezawa S, Yoshimitsu M, Higuchi K, Nakao S, Anan R, Minagoe S, Tei C. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol 2008, 51:50-59. 10.1016/j.jjcc.2007.12.001, 18522775.
6. O'Mahony C, Elliott P. Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 2010, 52:326-335.
7. Adams JE, Bodor GS, vila-Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993, 88:101-106.
8. Norris JW, Hachinski VC, Myers MG, Callow J, Wong T, Moore RW. Serum cardiac enzymes in stroke. Stroke 1979, 10:548-553.
9. Ay H, Koroshetz WJ, Benner T, Vangel MG, Melinosky C, Arsava EM, Zhu M, Schwamm LH, Sorensen AG. Neuroanatomic correlates of stroke-related myocardial injury. Neurology 2006, 66:1325-1329. 10.1212/01.wnl.0000206077.13705.6d, 16525122.
10. Brobbey A, Ravakhah K. Elevated serum cardiac troponin I level in a patient after a grand mal seizure and with no evidence of cardiac disease. Am J Med Sci 2004, 328:189-191. 10.1097/00000441-200409000-00012, 15367881.
11. Christensen H, Johannesen HH, Christensen AF, Bendtzen K, Boysen G. Serum cardiac troponin I in acute stroke is related to serum cortisol and TNF-alpha. Cerebrovasc Dis 2004, 18:194-199. 10.1159/000079941, 15273434.
12. Dixit S, Castle M, Velu RP, Swisher L, Hodge C, Jaffe AS. Cardiac involvement in patients with acute neurologic disease: confirmation with cardiac troponin I. Arch Intern Med 2000, 160:3153-3158. 10.1001/archinte.160.20.3153, 11074746.
13. Lim W, Cook DJ, Griffith LE, Crowther MA, Devereaux PJ. Elevated cardiac troponin levels in critically ill patients: prevalence, incidence, and outcomes. Am J Crit Care 2006, 15:280-288.
14. Stollberger C, Finsterer J. Cardiac troponin levels following monitored epileptic seizures. Neurology 2004, 62:1453.
15. Woodruff BK, Britton JW, Tigaran S, Cascino GD, Burritt MF, McConnell JP, Ravkilde J, Molgaard H, Andreasen F, Dam M, Jaffe AS. Cardiac troponin levels following monitored epileptic seizures. Neurology 2003, 60:1690-1692.
16. Topaloglu AK, Ashley GA, Tong B, Shabbeer J, Astrin KH, Eng CM, Desnick RJ. Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease. Mol Med 1999, 5:806-811. 2230489, 10666480.
17. Flisinski M, Strozecki P, Stefanska A, Zarzycka-Lindner G, Brymora A, Manitius J. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis. Kardiol Pol 2007, 65:1068-1075.
18. Iliou MC, Fumeron C, Benoit MO, Tuppin P, Courvoisier CL, Calonge VM, Moatti N, Buisson C, Jacquot C. Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study. Nephrol Dial Transplant 2001, 16:1452-1458. 10.1093/ndt/16.7.1452, 11427640.
19. Germain DP. Fabry disease. Orphanet J Rare Dis 2010, 5:30. 10.1186/1750-1172-5-30, 3009617, 21092187.
20. Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, Sunder-Plassmann G. Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet 2009, 46:548-552. 10.1136/jmg.2008.065904, 19473999.